TMCnet News

BUYINS.NET: JBHT, BIIB, TTEC, Expected to Trade Lower After Bearish Insider Trading
[September 01, 2011]

BUYINS.NET: JBHT, BIIB, TTEC, Expected to Trade Lower After Bearish Insider Trading


Sep 01, 2011 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. HUNT (J.B.) TRANSPORT SERVICES INCORPORATED (NASDAQ:JBHT), BIOGEN IDEC INC. (NASDAQ:BIIB), TELETECH HOLDINGS INC (NASDAQ:TTEC) are all expected to go Lower as Sell signals have been generated by top insider trading patterns.



The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns.

Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).


The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec.

JBHT HUNT (J.B.) TRANSPORT SERVICES INCORPORATED Simpson, Shelley OX 4,000 75 -6.8% 9 BIIB BIOGEN IDEC INC. Young, William D D 10,000 75 -11.1% 4 TTEC TELETECH HOLDINGS INC Barlett, James Edward OD 25,000 97 -9.3% 25 The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

HUNT (J.B.) TRANSPORT SERVICES INCORPORATED (NASDAQ:JBHT) - J.B. Hunt Transport Services, Inc., together with its subsidiaries, operates as a surface transportation and delivery services company in North America. It provides flatbed, refrigerated, expedited, and less-than-truckload, as well as various dry-van and intermodal solutions. The company transports a range of freight, including general merchandise, specialty consumer items, appliances, forest and paper products, building materials, soaps and cosmetics, automotive parts, electronics, and chemicals. As of December 31, 2009, it operated 40,170 company-controlled containers and managed a fleet of 2,303 company-owned tractors; 969 company-controlled trucks, 358 customer-owned trucks, and 31 independent contractor trucks; and 1,698 company-owned tractors. The company was founded in 1961 and is headquartered in Lowell, Arkansas.

BIOGEN IDEC INC. (NASDAQ:BIIB) - Biogen Idec Inc., a biotechnology company, discovers, develops, manufactures, and markets therapeutics in the areas of neurology, immunology, hemophilia, and oncology in the United States and internationally. Its marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkins Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe plaque psoriasis in adult patients. The companys products under Phase III consist of FAMPYRA, an oral compound that is being developed as a treatment to enhance walking ability in people with MS; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis; Recombinant Factors VIII and IX for the treatment of hemophilia; and GA101, a monoclonal antibody for the treatment of chronic lymphocytic leukemia and NHL. Its Phase I clinical trial products include Anti-LINGO, Baminercept, and Neublastin for neurology, as well as Anti-TWEAK and CD40LFab for immunology; and Phase II clinical trial products comprise Anti-TWEAK and Baminercept for immunology. In addition, the companys preclinical stage products consist of BIIB034 for the treatment of Parkinsons disease; and BART and Gamma Secretase Modulator for Alzheimers disease. It has collaboration agreements with Neurimmune SubOne AG; Genentech, Inc.; UCB, S.A.; Acorda Therapeutics, Inc.; Elan Pharma International, Ltd; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; Vernalis plc; and Amunix, Inc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is based in Weston, Massachusetts.

TELETECH HOLDINGS INC (NASDAQ:TTEC) - TeleTech Holdings, Inc. provides onshore, offshore, and work-from-home business process outsourcing services focusing on revenue generation, customer and enterprise management, and technology enabled solutions worldwide. Its revenue generation solutions provide a suite of integrated offerings that designs and manages approximately 8,000 client-branded e-commerce Websites, and processes 3 terabytes of customer data daily to create and implement customer targeting and segmentation strategies to optimize the revenue potential in every customer interaction. The companys customer innovation solutions are specifically tailored to enhance the customers end-to-end experience, helping build brand loyalty, and drive satisfaction across all customer interaction channels in traditional and emerging media. Its hosted technology solutions offer software and infrastructure on a hosted basis to enable companies to implement an end-to-end, customer management capability that facilitates interaction with customers across all touch points; and enterprise innovation solutions involve in the redesign of clients front- and back-office processes to advance clients abilities to obtain a customer-centric view of their relationships and to capitalize on up-sell and or cross-sell opportunities while optimizing the customer experience. The companys learning innovation solutions utilizes a methodology, which includes virtual job-simulation environments, eLearning courses, interactive social media networking and collaboration, as well as intuitive 3D and game-based learning courses to increase speed to proficiency and reduce learning curves and training expenses; and professional services deliver customer-centric solutions and strategies. It serves communications and media, financial services, government, healthcare, technology, transportation, and retail industries. TeleTech Holdings, Inc. was founded in 1982 and is headquartered in Englewood, Colorado.

About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected].

[ Back To TMCnet.com's Homepage ]